HAIFA, Israel--(BUSINESS WIRE)--Pluristem Therapeutics Inc. (NasdaqCM: PSTI) (DAX: PJT) today announced that it will chair a panel entitled: “Placenta-Derived Adult Stem Cells as an Allogeneic Alternative to Mesenchymal Stromal Cells (MSCs)” at the World Conference on Regenerative Medicine at the Congress Center Leipzig, in Leipzig, Germany. Edwin M. Horwitz, M.D., Ph.D., chairman of Pluristem’s scientific advisory board, will present, as the keynote speaker, the clinical landscape of MSCs and Pluristem’s clinical trial for the treatment of critical limb ischemia (CLI), an example of non-HLA matched allogeneic local delivery of placenta-derived MSCs, at 10:45 a.m. CET, Oct. 30, 2009.
